With 27 years of experience, GAIA is a global leader in scientifically validated digital treatments that achieve clinical outcomes comparable to pharmacological therapies. Our interventions are proven effective, safe, and scalable, supported by over 30 randomized clinical trials and widespread reimbursement across EU and the U.S.

At the core of our work is broca®, a rule-based AI platform that delivers fully automated, personalized treatments with precision and reliability—expanding access and impact for patients and pharma partners alike. Our solutions complement existing therapies, strengthen brand equity, and address unmet needs across CNS, Immunology, Women's Health and other therapeutic areas.